IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei

Currie, S., Rainbow, R.D., Ewart, M.-A., Kitson, S., Pliego, E.H., Kane, K.A. and McCarron, J.G. (2008) IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. Journal of Molecular and Cellular Cardiology, 45(6), pp. 804-811. (doi: 10.1016/j.yjmcc.2008.07.005)

Full text not currently available from Enlighten.

Abstract

Cannabinoids (CBs) are known to alter coronary vascular tone and cardiac performance. They also exhibit cardioprotective properties, particularly in their ability to limit the damage produced by ischaemia reperfusion injury. The mechanisms underlying these effects are unknown. Here we investigate the intracellular localisation of CB receptors in the heart and examine whether they may modulate localised nuclear Ca(2+) release. In isolated cardiac nuclear preparations, expression of both the inositol 1,4,5-trisphosphate receptor type 2 (IP(3)R) and CB receptors (CB(1)R and CB(2)R) was demonstrated by immunoblotting. Both receptors localised to the nucleus and purity of the nuclear preparations was confirmed by co-expression of the nuclear marker protein nucleolin but absence of cytoplasmic actin. To measure effects of IP(3)R and CBR agonists on nuclear Ca(2+) release, isolated nuclei were loaded with Fluo5N-AM. This dye accumulates in the nuclear envelope. Isolated nuclei responded to IP(3) with rapid and transient Ca(2+) release from the nuclear envelope. Anandamide inhibited this IP(3)-mediated release. Preincubation of nuclear preparations with either the CB(1)R antagonist (AM251) or the CB(2)R antagonist (AM630) reversed anandamide-mediated inhibition to 80% and 60% of control values respectively. When nuclei were pre-treated with both CBR antagonists, anandamide-mediated inhibition of IP(3)-induced Ca(2+) release was completely reversed. These results are the first to demonstrate the existence of cardiac nuclear CB receptors. They are also the first to show that anandamide can negatively modulate IP(3)-mediated nuclear Ca(2+) release. As such, this provides evidence for a novel key mechanism underlying the action of CBs and CBRs in the heart.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Kitson, Miss Susan and Ewart, Dr Marie-Ann
Authors: Currie, S., Rainbow, R.D., Ewart, M.-A., Kitson, S., Pliego, E.H., Kane, K.A., and McCarron, J.G.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Journal of Molecular and Cellular Cardiology
ISSN:0022-2828

University Staff: Request a correction | Enlighten Editors: Update this record